Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy and Safety of Microtransplantation for Advanced and Relapsed Solid Tumors
Sponsor: The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Summary
In this study, microtransplantation (MST) will be administrated to patients diagnosed with advanced / relapsed solid tumors to assess the therapeutic efficacy and safety of conventional chemotherapy in combination with MST for the treatment of advanced/relapsed solid tumors.
Key Details
Gender
All
Age Range
18 Years - 90 Years
Study Type
INTERVENTIONAL
Enrollment
10
Start Date
2026-01-15
Completion Date
2028-06-01
Last Updated
2026-01-21
Healthy Volunteers
No
Conditions
Interventions
MST
conventional chemotherapy with microtransplantation(MST). Microtransplantation, which is the infusion of granulocyte colony stimulating factor (G-CSF) mobilized HLA-mismatched peripheral blood mononuclear cells (GPBMC)
Locations (3)
Innovvy(Beijing) Biomedical Technology Co., Ltd
Haidian, Beijing Municipality, China
Minzu Hospital of Guangxi Zhuang Autonomous Region
Nanning, Guangxi, China
The First People's Hospital of Nanning
Nanning, Guangxi, China